In conclusion, we provide evidence that GYY4137 decreases myocardial fibrosis, which may be related to inhibition of oxidative stress, blockage of TGF-β1/Smad2 signaling pathway, and decrease in expression of α-SMA in cardiac fibroblasts. The gene discussed is TGFB1; the disease is Myocardial fibrosis.